Loading the section…
Closing prices for 9 October 2026
Next earnings report: 3 November 2026, before market open · Earnings calendar
Change over the period shown (line colour): −5.22 %
The series is stated in the current share scale after splits; dividends are not included in the price
BioNTech SE trades on Nasdaq under the ticker BNTX. The company belongs to the Health care sector. The trading history on this page starts on 10 October 2019.
Over the past 52 weeks BNTX has traded between 79.52 $ and 124.00 $. As of 9 October 2026 the price stood 39.21 % of the way from the 52-week low to the high.
Over one year BNTX shares fell 8.77 %; over six months they rose 1.53 %. Volatility over 90 days is 47.02 %. Dividends are not included: this is price change only, as of 9 October 2026.
BioNTech SE reported revenue of 2.9B € and a net loss of 1.1B € for the latest fiscal year. Net margin is −39.59 %. Revenue changed by +4.32 % year over year. Earnings per share are −4.70 €.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 9 October 2026 | 92.45 | 97.40 | 92.30 | 96.96 | 1M |
| 8 October 2026 | 93.81 | 94.45 | 91.64 | 92.06 | 1M |
| 7 October 2026 | 95.17 | 97.46 | 93.92 | 95.25 | 828,000 |
| 6 October 2026 | 99.49 | 100.02 |
Based on the fiscal year ended 31 December 2025
The sector median covers every company in the sector on the US market, loss-making ones included.
BioNTech SE (BNTX) is a public company in the healthcare sector. Its depositary receipts trade on NASDAQ.
Over the trailing twelve months as reported to 2025-12-31, revenue was 2.9bn €, net income was -1.1bn €. Incorporated in DE.
This summary is compiled automatically from SEC filings and exchange data.
Address:AN DER GOLDGRUBE 12, MAINZ, 55131, DE
BNTX has a return on equity of −5.91 %, above the sector median of −41.68 %. Return on assets is −5.17 %, above the sector median of −32.11 %. Operating margin is −48.95 %, below the sector median of −26.84 %.
| 4M |
| MESOMesoblast Limited | 14.29 | +3.93 % | 3M |
| AUTLAutolus Therapeutics plc | 1.81 | +2.26 % | 3M |
| CLLSCellectis S.A. | 1.26 | +0.80 % | 251,906 |
| VALNValneva SE | 5.78 | +1.58 % | 190,558 |
| 95.31 |
| 95.73 |
| 899,400 |
| 5 October 2026 | 96.74 | 98.79 | 95.20 | 97.64 | 1M |
| 2 October 2026 | 97.35 | 98.00 | 96.22 | 96.90 | 696,000 |
| 1 October 2026 | 97.59 | 99.49 | 96.60 | 96.85 | 820,000 |
| 30 September 2026 | 98.28 | 99.14 | 96.90 | 98.30 | 845,100 |
| 29 September 2026 | 98.43 | 99.79 | 97.60 | 98.57 | 736,900 |
| 28 September 2026 | 97.00 | 100.21 | 96.64 | 99.08 | 781,200 |
| 25 September 2026 | 99.51 | 100.02 | 97.73 | 98.52 | 580,000 |
| 24 September 2026 | 97.62 | 99.93 | 97.05 | 99.26 | 803,400 |
| 23 September 2026 | 100.61 | 101.31 | 98.31 | 98.46 | 1M |
| 22 September 2026 | 98.00 | 102.23 | 97.46 | 100.87 | 1M |
| 21 September 2026 | 97.25 | 98.98 | 96.61 | 98.00 | 800,800 |
| 18 September 2026 | 98.81 | 99.25 | 95.71 | 96.06 | 1M |
| 17 September 2026 | 97.50 | 99.58 | 97.13 | 98.66 | 708,000 |
| 16 September 2026 | 97.24 | 97.32 | 95.32 | 95.83 | 407,500 |
| 15 September 2026 | 97.04 | 97.66 | 95.80 | 96.69 | 590,400 |
| 14 September 2026 | 102.01 | 103.00 | 97.95 | 98.86 | 1M |